Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SETAP: Sitafloxacin vs Ertapenem for ESBL E. coli Acute Pyelonephritis
NCT02537847Phase 2Unknown
- Sponsor
- Mahidol University
- Start
- Nov 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitafloxacin in acute pyelonephritis, Escherichia coli infection, sponsored by Mahidol University. Status: unknown.
02
Drugs
sitafloxacin
03
Conditions
acute pyelonephritisEscherichia coli infection
Beyond the preview
Go deeper on NCT02537847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537847.